Search for stocks /

Aster DM Healthcare Q2 FY26 Concall Decoded: The Merger Prescription Finally Kicks In – 13% Growth, 22% Margins, and Kerala’s Comeback Story


1. Opening Hook

If hospitals could run on adrenaline, Aster DM’s Q2 FY26 would be a Code Blue success story. Kerala’s recovery was so sharp it could cut through last year’s gloom. After two sluggish quarters, leadership swaps, and vector-borne disease drama, the doctors finally wrote a better prescription — steady growth, fat margins, and a merger that’s more real than PowerPoint synergy slides.

But wait — the merger with QCIL promises a 10,000-bed healthcare behemoth and a clinical-oncology-fueled EBITDA surge. It’s not just healthcare, it’s healthcare with ambition. Read on — this call has more layers than a CT scan. 😏


2. At a Glance

  • Revenue up 10% – No steroids needed; just a clean shot of operational discipline.
  • Operating EBITDA up 13% – Kerala’s recovery gave the balance sheet its vitamin boost.
  • Margins at 22% – The CFO calls it efficiency; the traders call it relief.
  • PAT up 14% YoY – Flatlines avoided, profitability pulse strong.
  • Kerala cluster +24% QoQ – The comeback kid of Indian healthcare.
  • Stock buzzing post-merger updates – Investors heard “synergy” and stopped reading.

3. Management’s Key Commentary

Alisha Moopen: “For 20 consecutive quarters, Aster has delivered YoY growth — a reflection of our foresight and discipline.”
(Translation: If only consistency paid like consultation fees, we’d be minting crores per minute.) 😎

Ramesh Kumar: “Kerala delivered its highest-ever revenue of ₹620 Cr, with MVT up 67% QoQ.”
(Translation: Malayali medical tourism is back, and so are the Gulf wallets.)

Sunil Kumar: “Operating EBITDA margins expanded 200 bps to 22%, driven by cost control and renewable energy.”
(Translation: Solar panels are now officially part of our EBITDA strategy.)

Varun Khanna (QCIL): “EBITDA margins improved to 24.1% — thanks to procurement synergies and better payor mix.”
(Translation: Bulk discounts and better-insured patients are the new superheroes.)

Alisha Moopen: “Merger approvals from BSE and NSE are in; NCLT next.”
(Translation: Bureaucracy almost over — now we can start pretending the synergy is real.)

Sunil Kumar: “We added 200+ beds this year, total capacity now at 5,199.”
(Translation: We’re building hospitals faster than some cities build roads.)

Ramesh Kumar:

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!